出典: meddic


WordNet   license wordnet

「any of various disorders of lipoprotein and cholesterol metabolism that result in high levels of lipoprotein and cholesterol in the circulating blood」

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/11/19 16:53:54」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
  • Al-Allaf FA1, Athar M2, Abduljaleel Z3, Taher MM4, Khan W5, Ba-Hammam FA6, Abalkhail H7, Alashwal A7.
  • Gene.Gene.2015 Jul 1;565(1):76-84. doi: 10.1016/j.gene.2015.03.064. Epub 2015 Apr 1.
  • Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease characterized by elevated plasma low-density lipoprotein cholesterol (LDL-C). It is an autosomal dominant disease, caused by variants in Ldlr, ApoB or Pcsk9, which results in high levels of LDL-cholesterol (LDL-C) leading
  • PMID 25839937
  • Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.
  • Kastelein JJ1, Besseling J2, Shah S3, Bergeron J4, Langslet G5, Hovingh GK2, Al-Saady N6, Koeijvoets M7, Hunter J8, Johnson-Levonas AO9, Fable J3, Sapre A10, Mitchel Y3.
  • Lancet (London, England).Lancet.2015 May 30;385(9983):2153-61. doi: 10.1016/S0140-6736(14)62115-2. Epub 2015 Mar 3.
  • BACKGROUND: Present guidelines emphasise the importance of low concentrations of LDL cholesterol (LDL-C) in patients with familial hypercholesterolaemia. In most patients with the disease, however, these concentrations are not achieved with present treatments, so additional treatment is therefore wa
  • PMID 25743173
  • Anacetrapib in familial hypercholesterolaemia: pros and cons.
  • Raal FJ1, Blom DJ2.
  • Lancet (London, England).Lancet.2015 May 30;385(9983):2124-6. doi: 10.1016/S0140-6736(14)62315-1. Epub 2015 Mar 3.
  • PMID 25743172


  • 続発性高脂血症の分類と発症メカニズム (特集 脂質異常症診療のエビデンスと将来展望)
  • A case of pseudohomozygous type II hyperlipoproteinemia in early infancy
  • TAMAKI Wataru,FUJIEDA Mikiya,MAEDA Masato,HOSOKAWA Takatoshi,MORITA Hideo,ASAMI Tadashi,WAKIGUCHI Hiroshi
  • Pediatrics international : official journal of the Japan Pediatric Society 53(1), 110-113, 2011-02-01
  • NAID 10029557390
  • 症例 一過性の高脂血症に伴った発疹性黄色腫の1例
  • 遠田 博,加藤 英行,上山 泰淳 [他]
  • 皮膚科の臨床 53(1), 117-119, 2011-01
  • NAID 40017659723


Hyperlipoproteinemia 上げられたレベルの存在はのある 脂蛋白質 血。 脂質 (脂肪質の分子) a で運ばれる 蛋白質 カプセル、 そして蛋白質の脂質そしてタイプの密度は粒子および影響の運命を定める 新陳代謝。 言葉のhyperlipoproteinemia ...
Hyperlipoproteinemia Definition Hyperlipoproteinemia occurs when there is too much lipid (fat) in the blood. Shorter terms that mean the same thing are hyperlipidemia and hyperlipemia. Dyslipidemia refers to a redistribution of ...


 hyperlipoproteinemia. Circulation 1965;31Omega-3 and Other Novel Pharmacological Hyperlipoproteinemia Type Ii of HyperlipoproteinemiasHyperlipoproteinemia Type I Hyperlipoproteinemia type iii; Broad Beta

拡張検索hyperlipoproteinemia type II」「hyperlipoproteinemia type V」「familial type III hyperlipoproteinemia」「familial hyperlipoproteinemia type IV



[show details]

hyperlipoproteinemia type II」



familial hypercholesterolemiatype II hyperlipoproteinemia

hyperlipoproteinemia type V」



type V hyperlipoproteinemia

familial type III hyperlipoproteinemia」

  [★] 家族性高リポ蛋白血症III型

familial hyperlipoproteinemia type IV」

  [★] 家族性高リポ蛋白血症IV型